Stay updated on SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.

Latest updates to the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page
- Check4 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the previous study record content, indicating the page is blocked from access. The header/footer remain visible while the main content is replaced by an access-denied message.SummaryDifference22%

- Check11 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision tag on the page was updated from v3.6.5 to v3.6.6. This indicates a minor update to the page's documentation metadata.SummaryDifference0.0%

- Check45 days agoChange DetectedThe site's underlying version was updated from v3.6.4 to v3.6.5, representing a small patch that does not change the study details presented on the page.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a new build deployment. This appears to be an internal update with no described user-facing content changes.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3. This indicates a minor maintenance update with no changes to the study details.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous v3.6.0. This reflects a site release update rather than modifications to the study content.SummaryDifference0.0%

Stay in the know with updates to SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.